Medicure (MCUJF) Return on Sales [ROS] (2009 - 2026)
Medicure (MCUJF) posted Return on Sales [ROS] of -18.22% for the quarter ended Jun 30, 2026, down 7.74 percentage points from -10.48% a year earlier and down 87.20 percentage points from the prior quarter.
Medicure (MCUJF) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Medicure was 50.18%, up 21.02 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 4.46%, down 18.86 percentage points from the prior year.
- Annual Return on Sales [ROS] has declined for three consecutive years, though with a five-year change of +74.28 percentage points (years ended Dec 2020 to Dec 2025).
- In prior years, Medicure's Return on Sales [ROS] was 23.32% in the year ended Dec 31, 2024 (-2.88 pp), 26.20% in the year ended Dec 31, 2023 (-9.10 pp), 35.29% in the year ended Dec 31, 2022 (+44.92 pp) and -9.63% in the year ended Dec 31, 2021 (+60.20 pp).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Return on Sales [ROS] since the quarter ended Jun 30, 2024.
- On a year-over-year basis, Return on Sales [ROS] increased in four of the last eight quarters, with an average year-over-year change of +8.14 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was the quarter ended Sep 30, 2022, with a gain of 120.47 percentage points; the weakest was the quarter ended Sep 30, 2023, with a drop of 103.91 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 68.98% (quarter ended Mar 31, 2026), 81.92% (quarter ended Dec 31, 2025) and 60.94% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 28.37% |
| 10 | Medicure | 210.81 Mn | 202.62 Mn | 2.31 Mn | -18.22% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -18.22% |
| Mar 31, 2026 | 68.98% |
| Dec 31, 2025 | 81.92% |
| Sep 30, 2025 | 60.94% |
| Jun 30, 2025 | -10.48% |
| Mar 31, 2025 | 18.49% |
| Dec 31, 2024 | 95.74% |
| Sep 30, 2024 | 16.09% |
| Jun 30, 2024 | -21.65% |
| Mar 31, 2024 | 33.77% |
| Dec 31, 2023 | 114.55% |
| Sep 30, 2023 | 1.82% |
| Jun 30, 2023 | 5.46% |
| Mar 31, 2023 | 103.66% |
| Dec 31, 2022 | 114.55% |
| Sep 30, 2022 | 105.73% |
| Jun 30, 2022 | -13.29% |
| Mar 31, 2022 | 40.82% |
| Dec 31, 2021 | 4.84% |
| Sep 30, 2021 | -14.74% |
Medicure Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=MCUJF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "MCUJF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=MCUJF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();